Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Wenle Xia"'
Autor:
Mark Oldham, Paul Yoon, Zak Fathi, Wayne F Beyer, Justus Adamson, Leihua Liu, David Alcorta, Wenle Xia, Takuya Osada, Congxiao Liu, Xiao Y Yang, Rebecca D Dodd, James E Herndon, Boyu Meng, David G Kirsch, H Kim Lyerly, Mark W Dewhirst, Peter Fecci, Harold Walder, Neil L Spector
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162078 (2016)
This work investigates X-PACT (X-ray Psoralen Activated Cancer Therapy): a new approach for the treatment of solid cancer. X-PACT utilizes psoralen, a potent anti-cancer therapeutic with current application to proliferative disease and extracorporeal
Externí odkaz:
https://doaj.org/article/7f8a822b29f64920acbd0e793ca8a94f
Autor:
Wenle Xia, David Gooden, Leihua Liu, Sumin Zhao, Erik J Soderblom, Eric J Toone, Wayne F Beyer, Harold Walder, Neil L Spector
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88983 (2014)
Photo-activation of psoralen with UVA irradiation, referred to as PUVA, is used in the treatment of proliferative skin disorders. The anti-proliferative effects of PUVA have been largely attributed to psoralen intercalation of DNA, which upon UV trea
Externí odkaz:
https://doaj.org/article/1d28ff245e1449448ba258d2b2a9f600
Autor:
Timothy M. Clay, H. Kim Lyerly, Michael A. Morse, Andrea Amalfitano, Gayathri Devi, Amy Hobeika, William Barry, Jeffrey Marks, Neil Spector, Wenle Xia, Dong-Wan Kim, Sharon Peplinski, Xiao-Yi Yang, Gangjun Lei, Oliver Glass, Takuya Osada, Junping Wei, Zachary C. Hartman
Purpose: Overexpression of the breast cancer oncogene HER2 correlates with poor survival. Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease. Because refractory tumors remain strongly HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6ac360f8f5c8a5381395d6c60f3fc6
https://doi.org/10.1158/1078-0432.c.6518551.v1
https://doi.org/10.1158/1078-0432.c.6518551.v1
Autor:
Neil L. Spector, Sarah Bacus, Sumin Zhao, Ron E. Westlund, Qiaoyin Liao, Michael Dush, Mary Ann Hardwicke, Amanda L. Treece, Katherine M. Graham, Kevin Carrick, Leihua Liu, Jay Strum, John Bisi, Wenle Xia
Supplementary Figure S4 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8d9b87d7a432816e17e94addcd8727
https://doi.org/10.1158/0008-5472.22365881.v1
https://doi.org/10.1158/0008-5472.22365881.v1
Autor:
Neil L. Spector, Sarah Bacus, Sumin Zhao, Ron E. Westlund, Qiaoyin Liao, Michael Dush, Mary Ann Hardwicke, Amanda L. Treece, Katherine M. Graham, Kevin Carrick, Leihua Liu, Jay Strum, John Bisi, Wenle Xia
In breast cancer, overexpression of ErbB2 or aberrant regulation of survivin, a member of the inhibitor of apoptosis family, is associated with resistance to chemo/hormone therapy and predicts for a poor clinical outcome. A functional link between th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f942b7ad01e3976e35892915488af6a
https://doi.org/10.1158/0008-5472.c.6494900.v1
https://doi.org/10.1158/0008-5472.c.6494900.v1
Autor:
Neil L. Spector, Sarah Bacus, Sumin Zhao, Ron E. Westlund, Qiaoyin Liao, Michael Dush, Mary Ann Hardwicke, Amanda L. Treece, Katherine M. Graham, Kevin Carrick, Leihua Liu, Jay Strum, John Bisi, Wenle Xia
Supplementary Table S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a2953090345f4949e91f7810265d291
https://doi.org/10.1158/0008-5472.22365875
https://doi.org/10.1158/0008-5472.22365875
Publikováno v:
Nano letters. 22(20)
The construction of luminescent gold nanoparticles (AuNPs) with highly redshifted emission in the second near-infrared window (NIR-II) and good biocompatibility is still challenging. Herein, using an amphiphilic block copolymer (ABC) template with co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efd77a3b3398505c0aecc853f906416
https://pubmed.ncbi.nlm.nih.gov/36214567
https://pubmed.ncbi.nlm.nih.gov/36214567
Publikováno v:
Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Background Research on the prevalence of irritable bowel syndrome (IBS) among polycystic ovary syndrome (PCOS) patients has gained significant momentum over the years. However, it remains unclear whether PCOS is related to a higher prevalence of IBS.
Externí odkaz:
https://doaj.org/article/6ae69d0c9fcb479382414d885ab782cb
Publikováno v:
Talanta. 193
Heparin (Hep) is a widely applied anticoagulant and the quantification of heparin concentration is pivotal for clinical use. In this work, silicon nanoparticles (SiNPs) modified by the amino groups and glutathione-capped gold nanoclusters (GSH-AuNCs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b7eab99bf9d455a0bb2f0560093ca6
https://pubmed.ncbi.nlm.nih.gov/30368295
https://pubmed.ncbi.nlm.nih.gov/30368295
Autor:
Wenle Xia1, Gerard, Catherine M.2, Leihua Liu1, Baudson, Nathalie M.2, Ory, Thierry L.2, Spector, Neil L.1 Neil.L.Spector@gsk.com
Publikováno v:
Oncogene. 9/15/2005, Vol. 24 Issue 41, p6213-6221. 9p. 4 Diagrams.